John C.M. Farquhar Sells 15,560 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) CEO John C.M. Farquhar sold 15,560 shares of the business’s stock in a transaction on Friday, August 14th. The stock was sold at an average price of $39.06, for a total transaction of $607,773.60. Following the transaction, the chief executive officer directly owned 420,720 shares in the company, valued at $16,433,323.20. This trade represents a 3.57% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

Get Heartflow alerts:

• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total transaction of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $35.00, for a total transaction of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.

Heartflow Stock Performance

NASDAQ HTFL opened at $45.53 on Thursday. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $47.23. The stock has a market cap of $3.96 billion and a PE ratio of -24.88. The firm has a 50-day simple moving average of $30.00 and a 200 day simple moving average of $28.05.

Heartflow (NASDAQ:HTFL – Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm had revenue of $64.08 million during the quarter. The firm’s revenue for the quarter was up 47.7% on a year-over-year basis. Research analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.

Institutional Trading of Heartflow

Several institutional investors have recently bought and sold shares of HTFL. XXEC Inc. acquired a new position in Heartflow during the second quarter worth $2,524,764,000. BlackRock Inc. acquired a new stake in shares of Heartflow in the 2nd quarter valued at $152,502,000. Wellington Management Group LLP bought a new stake in shares of Heartflow in the 3rd quarter worth about $164,263,000. Bamco Inc. NY bought a new stake in shares of Heartflow in the 2nd quarter worth about $94,625,000. Finally, Jupiter Topco LLC acquired a new stake in shares of Heartflow during the 2nd quarter worth about $70,983,000.

Analysts Set New Price Targets

Several brokerages recently commented on HTFL. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. JPMorgan Chase & Co. boosted their price target on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Canaccord Genuity Group raised their price objective on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. Wells Fargo & Company lifted their target price on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Finally, Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a research note on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Heartflow has an average rating of “Moderate Buy” and a consensus target price of $43.43.

Check Out Our Latest Research Report on HTFL

Heartflow Company Profile

(Get Free Report)

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

Featured Articles

• Five stocks we like better than Heartflow
• Bloom Energy’s AI Surge Meets a Valuation Reality Check
• Target Is Winning Shoppers Back—Can the Rally Reach $180?
• IonQ’s Space Contract Points to a New Frontier for Quantum Investors
• Is Apple’s AI Strategy Smarter Than Skeptics Think?

Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.